Hydrogen Water and Fatty Liver — What a 2019 Pilot Trial Found
A 2019 randomised, double-blind, placebo-controlled crossover pilot trial in Clinical Nutrition ESPEN tested 28 days of hydrogen-rich water in 12 overweight adults with mild-to-moderate non-alcoholic fatty liver disease. The hydrogen group showed roughly a 20 percent reduction in liver fat content, independent of any change in body weight, alongside improvements in liver-enzyme profiles.
Red Light Therapy and Hair Loss — What Two Trials in Men and Women Found
Two randomised, double-blind, sham-controlled trials in Lasers in Surgery and Medicine tested 16 weeks of home-use 655 nm red-light therapy in 41 men (2013) and 47 women (2014) with androgenetic alopecia. The active groups showed a 39 percent (men) and 37 percent (women) increase in terminal hair counts at 16 weeks compared with sham (both p < 0.0001).
Hydrogen Water and Gut Health — What a 2021 Review of Early Evidence Found
A 2021 narrative review in the Journal of Functional Foods examined how hydrogen-rich water may shape the gut microbiome — from feeding hydrogen-producing bacteria and upregulating butyrate-producing species to protecting the intestinal barrier — based on rodent studies and one human RCT.
Red Light Therapy and Post-Mastectomy Lymphedema — What a Randomised Trial in Cancer Found
A 2003 randomised, double-blind, placebo-controlled trial in the journal Cancer tested low-level laser therapy in 64 women with chronic post-mastectomy arm lymphedema. Two cycles of LLLT produced significant reductions in affected limb volume, tissue induration, and pain at three-month follow-up compared with sham — a foundational reference for photobiomodulation in lymphedema care.
Hydrogen Inhalation and Heart Attack Recovery — What the First Human Pilot Found
A 2017 first-in-human pilot study in the Circulation Journal tested hydrogen gas inhalation during emergency stenting for ST-elevation myocardial infarction. The intervention proved feasible and safe in 20 patients, with an exploratory signal of improved left-ventricular reverse remodelling at 6 months — establishing the safety foundation for the larger trials needed to confirm clinical efficacy.
Hydrogen Water and Quality of Life During Radiotherapy — What a 2011 Trial Found
A 2011 randomised, placebo-controlled trial in Medical Gas Research tested hydrogen-rich water in 49 patients receiving radiotherapy for liver tumours. Six weeks of drinking hydrogen-rich water significantly improved quality of life on the EORTC QLQ-C30 scale and reduced blood markers of oxidative stress — without changing tumour response to radiotherapy.
Hydrogen Gas in Cancer Care — A Review of Clinical Evidence
A 2019 review in Frontiers in Oncology examined hydrogen gas across preclinical and early clinical cancer research — covering side effect reduction, organ protection, and direct anti-tumour effects. Here is what the evidence shows.
Hydrogen Therapy and Haemodialysis — What a Bioactive Dialysis Trial Showed
A 2010 clinical trial in Nephrology Dialysis Transplantation tested a novel haemodialysis system delivering hydrogen-enriched dialysis solution to chronic dialysis patients. The treatment reduced post-dialysis blood pressure, lowered the need for antihypertensive medication, decreased systemic inflammation markers (MCP-1, MPO), and eased chronic dialysis-related fatigue.